FDA Issues Guidance Documents On Exploratory INDs

Executive Briefing Series
A A

The FDA has released a series of guidances and a final rule aimed at speeding products to market by streamlining the investigational new drug (IND) application process.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00